Realyze Intelligence – NO MORE ZOMBIE TRIALS
Realyze Intelligence shared a post on LinkedIn:
“NO MORE ZOMBIE TRIALS
But what IS a zombie trial???
It’s a clinical trial that a cancer center has spent precious resources opening….but which never enrolls a single patient.
Zombie trials are a huge waste of institutional resources and a devastating missed opportunity for cancer patients
During a recent CancerX Moonshot Accelerator curriculum call, the director of Atrium Health Levine Cancer Center — Ruben Mesa, MD — shared the term ‘zombie trial’ and how much he *hates* them.
How is Realyze Intelligence working to defeat zombie trials ?
Our platform is designed to accelerate research as care. The technology can read all parts of the patient health record (clinical notes, scanned documents, pathology reports, etc) and creates rich, Real-World Data summarized at the patient level.
We can then automatically & accurately screen 100% of cancer patients for all open clinical trials at a research site. By screening all patients, we ensure that no patient is left behind. At a National Cancer Institute (NCI)-designated comprehensive cancer center, we increased patient matches by >7-fold.
No surprise : 100% screening = more matches = more enrolled patients.
But 100% patient screening won’t correct for bad trial design. We know that. That’s why our platform enables you to see exactly which inclusion/exclusion criteria are preventing patient enrollment. Even better, we facilitate rapid, real-timw feasibility queries for future trials. Together, this can lead to better trial design and empower sites to only open trials that will benefit their patients.
Win-Win-Win.
NO MORE ZOMBIE TRIALS
Ready to slay zombie trials at your site? You know where to find us! ”
Source: Realyze Intelligence/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023